Diabetes
News
FDA approves Baqsimi nasal powder for emergency hypoglycemia treatment
It is the first glucagon therapy approved for this indication that is administrable without an injection.
Conference Coverage
Type 2 diabetes is particularly devastating in adolescents
SAN FRANCISCO – “These kids have problems you’d expect in their grandparents.” – Dr....
News
FDA issues warning on insulin pump cybersecurity weakness
The MiniMed 508 and MiniMed Paradigm series insulin pumps are being recalled because of potential cybersecurity risks; 4,000 patients in the...
News
Liraglutide indication expanded to include children
The approval marks the first noninsulin drug approved for pediatric use in almost 20 years.
Conference Coverage
Immunotherapy drug teplizumab may stall onset of type 1 diabetes
The monoclonal antibody teplizumab may delay the onset of type 1 diabetes in individuals at high risk of developing the disease.
From the Journals
Diabetes, hypertension remission more prevalent in adolescents than adults after gastric bypass
However, their rate of abdominal reoperations was significantly higher than that of adults during a 5-year follow-up.
Conference Coverage
Liraglutide seems safe, effective in children already on metformin
Liraglutide seems to be safe and effective for children and adolescents with type 2 diabetes who are already on metformin therapy.
Latest News
Cigna, Express Scripts to offer $25 cap on 30-day insulin supply
The new patient assistance program would cap out-of-pocket costs for a 30-day supply of insulin at $25.
From the Journals
More sleep can help youth manage type 1 diabetes
More sleep can lead to better glycemic control in youth with type 1 diabetes mellitus.
From the Journals
Insulin-treated diabetes in pregnancy carries preterm risk
Pregnant women with insulin-treated diabetes or obesity have a significantly greater odds of premature delivery or offspring who are large for...
From the Journals
AHA: Consider obesity as CVD risk factor in children
The updated AHA scientific statement is aimed at pediatric cardiologists and physicians who care for at-risk pediatric patients.